Pharmaceutical Executive June 30, 2021
An updated version of legislation to modernize clinical research policies and FDA expedited approval pathways is circulating on Capitol Hill in anticipation of gaining approval in the coming year. The latest “Cures 2.0” draft released by Reps. Diana DeGette (D-Col) and Fred Upton (R-Mich) also supports the creation of the Biden administration’s proposed Advanced Research Projects Agency for Health (ARPA-H) to accelerate research on cures for devastating diseases such as cancer, diabetes, Alzheimer’s and more.
The proposal builds on the initial 21st Century Cures legislation, which was developed on a bipartisan basis by DeGette and Upton in 2015 and aims to further improve how new critical treatments are tested and delivered to patients. The Cures 2.0 measure has been under...
Today's Sponsors
Today's Sponsor